-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Production Process of Calcium (βS,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2) in Chemical Industry
Calcium (βS,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2) is a highly complex organic compound that is widely used in the pharmaceutical industry as an intermediate for the synthesis of certain drugs.
It is a white or slightly yellowish solid that is insoluble in water but soluble in organic solvents.
The compound is a derivate of 1H-pyrrole-1-heptanoic acid, which is a naturally occurring compound found in small amounts in certain plants and bacteria.
The production process of Calcium (βS,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2) involves several stages, including the synthesis of the starting material, the purification of the intermediate product, and the isolation of the final product.
Each of these stages is complex and requires careful attention to detail in order to produce a high-quality product that meets the required specifications.
Synthesis of the Starting Material
The synthesis of Calcium (βS,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2) involves several steps, including the synthesis of the two starting materials, 2-(4-fluorophenyl)-3-phenyl-5-(1-methylethyl)-1H-pyrrole-1-heptanoic acid and (S)-(+)-2-phenylglycinamide.
These starting materials are then combined in a series of reaction steps to form the final product.
Purification of the Intermediate Product
After the synthesis of the starting materials, the intermediate product is purified to remove any impurities that may have been introduced during the synthesis process.
This step is crucial in ensuring the quality of the final product, as any impurities could have a detrimental effect on the product's efficacy or stability.
The purification process typically involves several different techniques, including crystallization, chromatography, and recrystallization.
Isolation of the Final Product
Once the intermediate product has been purified, it is ready to be isolated as the final product.
This step typically involves several stages, including the dissolution of the intermediate product in a suitable solvent, the addition of a precipitating agent to form crystals, and the filtration and drying of the crystals to remove any remaining impurities.
Quality Control and Stability Testing
After the final product has been isolated, it is subjected to a series of quality control tests to ensure that it meets the required specifications for purity, potency, and stability.
These tests may include spectroscopic analysis, chromatography, and microbiological testing.
The final product is also tested for physical characteristics such as pH, temperature stability, and solubility.
Conclusion
The production process of Calcium (βS,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2) is highly complex and requires careful attention to detail at each stage of the process.
The quality of the final product is critical, as it will determine the efficacy and safety of the drug that is eventually synthesized from